Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia Infections funds independent researchers studying treatment outcomes to improve patient care.
Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI) supports researchers studying diagnostic-guided treatment of resistant infections to assess timeliness and effectiveness.
Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment Options supports investigators studying tissue exposure to understand links to treatment outcomes.
Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia supports healthcare teams' local quality improvement projects to improve diagnosis, treatment, and adult care.
Pilot and Feasibility grants from the Alpha-1 Foundation support researchers testing new AAT deficiency hypotheses or methods to improve health, advance the search for a cure, and open new research directions.